0.1334

24.51% -0.1779

Zyversa Therapeutics Inc (ZVSA)

Overview News Price History Financials Why ZVSA Down? Discussions Forecast

Zyversa Therapeutics Inc stock is traded at $0.1334, with a volume of 30,675. It is down -24.51% in the last 24 hours and down -62.29% over the past month. ZYVERSA THERAPEUTICS INC

Previous Close:

$0.3113

Open:

$0.135986

24h Volume:

30,675

Relative Volume:

66.00

Market Cap:

$N/A

Revenue:

Net Income/Loss:

$-8.29M

P/E Ratio:

-0.0369

EPS:

-3.62

Net Cash Flow:

$-5.16M

1W Performance:

-24.51%

1M Performance:

-62.29%

6M Performance:

-84.44%

1Y Performance:

-93.80%

1-Day Range:

$0.1333

$0.1408

1-Week Range:

$0.1333

$0.1408

52-Week Range:

$0.1333

$0.1408

Zyversa Therapeutics Inc Stock (ZVSA) Company Profile

Name

Zyversa Therapeutics Inc

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ZVSA's Discussions on Twitter

Compare ZVSA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ZVSA Zyversa Therapeutics Inc	0.1334	0	0	-8.29M	-5.16M	-3.62
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Zyversa Therapeutics Inc Stock (ZVSA) Latest News

Dec 06, 2025

Investment Report: How risky is ZyVersa Therapeutics Inc stock nowWeekly Market Report & Daily Momentum Trading Reports - moha.gov.vn

Dec 06, 2025

Dec 05, 2025

Is ZyVersa Therapeutics Inc. stock a buy for dividend growthDollar Strength & Fast Entry High Yield Stock Tips - Newser

Dec 05, 2025

Dec 03, 2025

[8-K] ZyVersa Therapeutics, Inc. Reports Material Event | ZVSA SEC FilingForm 8-K - Stock Titan

Dec 03, 2025

Nov 25, 2025

ZyVersa Therapeutics Delays 10-Q Filing - MSN

Nov 25, 2025

Nov 20, 2025

Is ZyVersa Therapeutics Inc. stock safe for conservative investorsTrade Risk Assessment & Free High Return Stock Watch Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Zyversa Therapeutics Faces Financial Challenges Amid Drug Development - TipRanks

Nov 19, 2025

What institutional flow reveals about ZyVersa Therapeutics Inc.Trade Entry Summary & Fast Gaining Stock Strategy Reports - newser.com

Nov 19, 2025

A activityEntry Point & AI Powered Buy/Sell Recommendations - newser.com

Nov 19, 2025

ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results - The Manila Times

Nov 19, 2025

[10-Q] ZyVersa Therapeutics, Inc. Quarterly Earnings Report | ZVSA SEC FilingForm 10-Q - Stock Titan

Nov 19, 2025

ZyVersa Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 19, 2025

ZyVersa Therapeutics Inc. stock volume spike explainedPrice Action & Free Technical Confirmation Trade Alerts - newser.com

Nov 19, 2025

What makes ZyVersa Therapeutics Inc. stock attractive to growth fundsJuly 2025 Outlook & Stepwise Trade Signal Implementation - newser.com

Nov 19, 2025

Can ZyVersa Therapeutics Inc. stock hit record highs again2025 Investor Takeaways & Long-Term Safe Investment Plans - newser.com

Nov 19, 2025

Nov 17, 2025

Zyversa Therapeutics’ Promising Phase 2a Study on DKD Treatment - MSN

Nov 17, 2025

Nov 16, 2025